CB 1016 General Pathology I

At the conclusion of the course, students will be able to identify the morphological bases of different organ systems, as well as risk factors, in order to make diagnostic and therapeutic decisions. This will be achieved through bibliographic research, group discussions, critical discussion seminars and complementary practice in the Simulation and Virtual Teaching laboratory.

CB 1015 Anatomy II

The aim of this course is for students to describe the anatomical and functional details of the organs that make up the nervous  system, the digestive system, the urinary system, and the male and female genital systems. They should also be able to analyze abnormalities related to major diseases, with a clinical orientation.

CB 1014 Laboratory of Pharmacology and Pharmacogenetics

After completing this course, students will be able to understand the rational prescribing of medicines in order to apply pharmacokinetics and pharmacodynamics to calculate appropriate dosage in the best route of administration and prescribe drugs efficiently based on the patient's ethnicity, metabolic capacity, or genetic profile to prescribe customized pharmacological therapies based on the use of cutting-edge pharmacogenetic tools.

CB 1012 Introduction to Medicine

At the conclusion of the course, students will be able to identify the areas that make up the academic training of a physician. They will learn about the most significant milestones in the history of medicine and understand educational and evaluation strategies in contemporary medicine for the purpose of gaining a broad perspective of training in the medical profession. This will be achieved through theoretical knowledge addressed with a rational dynamics.

CB 1009 Pharmacology and Pharmacogenetics

After completing this course, students will be able to understand the rational prescribing of medicines in order to apply pharmacokinetics and pharmacodynamics to calculate appropriate dosage in the best route of administration and prescribe drugs efficiently based on the patient's ethnicity, metabolic capacity, or genetic profile to minimize the risk of adverse effects of customized pharmacological therapies.